NCT03008148 2021-05-11
Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM
Johnpro Biotech, Inc.
Phase 2/3 Unknown
Clinical Trials
4 trialsNCT03025893 2021-04-19
STELLAR
Amsterdam UMC, location VUmc
Phase 2/3 Unknown
NCT01759810 2017-10-12
Proteome-based Personalized Immunotherapy of Glioblastoma
NeuroVita Clinic
Phase 2/3 Unknown
NCT01308632 2011-03-04
Metronomic Temozolamide in Patients With Recurrent Glioblastoma
Grupo Español de Investigación en Neurooncología
Phase 2/3 Unknown